trending Market Intelligence /marketintelligence/en/news-insights/trending/69ggHsRLVFcNHgA_MfGGmA2 content esgSubNav
In This List

XTL Biopharmaceuticals regains compliance with Nasdaq listing rule

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


XTL Biopharmaceuticals regains compliance with Nasdaq listing rule

XTL Biopharmaceuticals Ltd. regained compliance with the minimum $2.5 million stockholders' equity requirement for continued listing on the Nasdaq Capital Market.

Nasdaq determined that the company is compliant with the listing rule after XTL showed that it had stockholders' equity of about $3.6 million as of Sept. 30.